XML 311 R71.htm IDEA: XBRL DOCUMENT v3.23.4
OTHER FINANCIAL ASSETS - Narrative (Details)
$ in Thousands, $ in Thousands
6 Months Ended 12 Months Ended 13 Months Ended
May 25, 2023
CAD ($)
May 25, 2023
USD ($)
tranches
Mar. 30, 2023
CAD ($)
vapeCartridge
Sep. 30, 2023
CAD ($)
Aug. 31, 2022
CAD ($)
Sep. 30, 2023
CAD ($)
Mar. 30, 2023
USD ($)
Disclosure of detailed information about financial instruments [line items]              
Cash advances and loans made to other parties, classified as investing activities         $ 8,439 $ 0  
Secured convertible loan advanced, period of extensions 1 year 1 year          
Loan receivable       $ 3,092   3,092  
Loan modification loss           52  
Cost              
Disclosure of detailed information about financial instruments [line items]              
Additions         30 2,710  
Cost | LICENSE AGREEMENTS              
Disclosure of detailed information about financial instruments [line items]              
Additions         $ 0 2,710  
Phylos Bioscience Inc. ("Phylos")              
Disclosure of detailed information about financial instruments [line items]              
Secured convertible loan advanced   $ 8,000          
Number of tranches, secured convertible loan advances | tranches   3          
Number of remaining tranches, secured convertible loan | tranches   2          
Paid-in-kind interest rate above US prime rate   3.50%          
Paid-in-kind interest rate cap   11.00%          
Phylos Bioscience Inc. ("Phylos") | Cost | LICENSE AGREEMENTS              
Disclosure of detailed information about financial instruments [line items]              
Additions           2,710  
Phylos Bioscience Inc. ("Phylos") | First              
Disclosure of detailed information about financial instruments [line items]              
Cash advances and loans made to other parties, classified as investing activities $ 4,429 $ 3,250          
Phylos Bioscience Inc. ("Phylos") | Second and third              
Disclosure of detailed information about financial instruments [line items]              
Secured convertible loan advanced   $ 4,750          
Phylos Bioscience Inc. ("Phylos") | Second              
Disclosure of detailed information about financial instruments [line items]              
Secured convertible loan, payment period 12 months 12 months          
Phylos Bioscience Inc. ("Phylos") | Third              
Disclosure of detailed information about financial instruments [line items]              
Secured convertible loan, payment period 24 months 24 months          
Weekend Holdings Corp. (“WHC”)              
Disclosure of detailed information about financial instruments [line items]              
Number of vape cartridges for use with cannabis | vapeCartridge     510        
Investments in equity instruments designated at fair value through other comprehensive income     $ 5,504 5,345   $ 5,345 $ 4,000
Preference shares subscription, transaction costs     $ 73        
Participating share     2.60%        
Other comprehensive income, net of tax, gains (losses) from investments in equity instruments       $ 159